Filing Flows › Pfizer (PFE) › Q1 2025
Pfizer (PFE) Q1 2025 earnings results (first quarter 2025)
10-Q filed May 5, 2025
Pfizer (PFE) reported revenue of $13.7B for the first quarter 2025 (Q1 2025), -8% from a year earlier and -23% from the quarter before. Operating margin was 20.3%, net earnings $3.0B (21.7% of revenue).
Pfizer, Q1 2025: revenue $13.7B (-8% year over year), operating margin 20.3%, net earnings $3.0B, operating cash flow $2.3B. The chart follows the revenue to costs, profit and cash.
| Q1 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $13.7B | -23% | -8% |
| Operating profit | $2.8B | — | -19% |
| Net earnings | $3.0B | +611% | -5% |
| Operating cash flow | $2.3B | -65% | +114% |
| Free cash flow | $1.8B | -69% | +359% |
What changed
Revenue was $13.7B in Q1 2025, down 8% year over year and down 23% from the previous quarter.
Operating profit was $2.8B, a 20.3% margin (down 2.7 points year over year). Total costs fell 5% while revenue fell 8%. The fastest-growing cost line was Other operating costs (+36%). Net earnings were $3.0B, down 5% year over year. The effective tax rate was -6.8%.
Operating cash flow was $2.3B (up 114% year over year), 79% of net earnings. Non-cash charges added back $1.6B of depreciation and amortization and $0.17B of share-based compensation. Working capital and other items used $2.4B. Capital expenditures of $0.56B left free cash flow of $1.8B.
Questions
What was Pfizer's revenue in the first quarter 2025?
Pfizer (PFE) reported revenue of $13.7B for the first quarter 2025 (Q1 2025), -8% from a year earlier and -23% from the quarter before.
Was Pfizer profitable in the first quarter 2025?
Operating profit was $2.8B (20.3% of revenue) and net earnings $3.0B.
Source: Pfizer 10-Q on SEC EDGAR.